Zynex has initiated a process to review potential strategic alternatives that could include a sale, people with knowledge of the matter said.

The medical device manufacturer is working with Cantor Fitzgerald to evaluate options, which may include any take-private offers, a merger, divestiture, recapitalization or any other transaction, according to the people, who asked not to be identified discussing confidential information.